Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising Neisseria meningitidis antigens from serogroups B and C

Compositions comprising Neisseria meningitidis antigens from serogroups B and C

US Patent 9636393 · Granted May 2, 2017

Estimated economic value: $18,543,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Meningococcus vaccines2025
Vaccines for Neisseria gonorrhoeae2024
Vaccines for Neisseria gonorrhoeae2024
Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a teta2024
Vaccines for Neisseria gonorrhoeae2024
Meningococcus vaccines2023
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses gro2023
Vaccination of immunocompromised subjects2022
Vitro potency assay for protein-based meningococcal vaccines2021
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses gro2020
Vaccination of immunocompromised subjects2020
Adjuvanted combinations of meningococcal factor H binding proteins2020